Page last updated: 2024-09-03

statine and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

statine has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 1 studies

Compound Research Comparison

Studies
(statine)
Trials
(statine)
Recent Studies (post-2010)
(statine)
Studies
(1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid)
Trials
(1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid)
Recent Studies (post-2010) (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid)
12864079216476

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gourni, E; Jamous, M; Maecke, HR; Mansi, R; Reubi, JC; Tamma, ML; Waser, B1

Other Studies

1 other study(ies) available for statine and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

ArticleYear
PEG spacers of different length influence the biological profile of bombesin-based radiolabeled antagonists.
    Nuclear medicine and biology, 2014, Volume: 41, Issue:6

    Topics: Amino Acids; Animals; Biological Transport; Bombesin; Cell Line, Tumor; Chelating Agents; Drug Stability; Female; Fluorenes; Heterocyclic Compounds, 1-Ring; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Polyethylene Glycols; Receptors, Bombesin; Structure-Activity Relationship; Tissue Distribution

2014